GlassScriptPhysician profile
Michael Richard Sinkoff
NPI 1720227002
$1,671.84
in general payments reported to CMS, 2019-2025
30 companies · $948 in 2025
The $948 reported for 2025 was more than what 88% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $56.26 · 2022: $230 · 2023: $211 · 2024: $227 · 2025: $948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,385.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $178.03 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $164.11 | 2023-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $159.95 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $143.18 | 2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $104.89 | 2025 | Rexulti |
| Pfizer INC. | $98.26 | 2024-2025 | |
| Abbott Laboratories | $79.34 | 2022-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $79.22 | 2023-2025 | Kisunla, Mounjaro, Zepbound |
| Amgen INC. | $79.08 | 2024-2025 | Evenity, Otezla, Repatha |
| Exact Sciences Corporation | $63.02 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.18 | 2023-2025 | Xifaxan |
| Lundbeck LLC | $53.25 | 2025 | Rexulti |
| Sumitomo Pharma America, INC. | $51.38 | 2023-2025 | Gemtesa |
| Corium, LLC | $48.31 | 2022-2023 | Adlarity, Azstarys |
| Sanofi-Aventis U.S. LLC | $39.80 | 2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $34.55 | 2025 | Zenpep |
| Glaxosmithkline, LLC. | $27.65 | 2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Ucb, INC. | $20.00 | 2021 | |
| Corcept Therapeutics | $19.62 | 2025 | Korlym |
| Acadia Pharmaceuticals INC | $18.57 | 2025 | Nuplazid |
| Regeneron Healthcare Solutions, INC. | $18.49 | 2025 | Evkeeza |
| Inspire Medical Systems, INC. | $18.44 | 2024 | Inspire |
| Vertex Pharmaceuticals Incorporated | $16.46 | 2025 | |
| Astellas Pharma US INC | $16.10 | 2023 | Veozah |
| Janssen Pharmaceuticals, INC | $15.99 | 2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.11 | 2024 | Jardiance, Synjardy |
| Medtronic, INC. | $14.99 | 2022 | |
| Abbvie INC. | $14.08 | 2021 | |
| Merck Sharp & Dohme LLC | $13.44 | 2024 | Capvaxive, Gardasil 9, Gardasil |
| Almatica Pharma LLC | $12.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sinkoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.